AB Science has received approval from the U.S. Food and Drug

AB Science has received approval from the U.S. Food and Drug Administration (FDA) to initiate the confirmatory Phase 3 study with masitinib in the treatment of progressive multiple sclerosis - read this article along with other careers information, tips and advice on BioSpace

Related Keywords

France , Paris , France General , French , Neuroimmunol Neuroinflamm , Patrick Vermersch , French Agency , University Of Lille , Drug Administration , Amyotrophic Lateral Sclerosis , Expanded Disability Status Scale , Progressive Forms , Multiple Sclerosis , Neurol Neuroimmunol Neuroinflamm , Euronext Paris , Resume , Careers , B Science Has Received Approval From The Us Food And Drug Administration Fda To Initiate Confirmatory Phase 3 Study With Masitinib In Treatment Of Progressive Multiple Sclerosis , Iospace , Advice ,